C5orf34

Model summary

A human cytosolic scaffold that concentrates at the centrosome and organizes multivalent protein assemblies. By using multiple noncatalytic binding modules, it recruits regulatory partners to repress RNA polymerase II–driven transcription while coupling to centrosomal and cytoskeletal pathways. This spatially organized repression is coordinated from the cytosol and centrosome, aligning transcriptional control with cell-cycle–linked microtubule architecture.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is covered end-to-end by IPR053901 (C5orf34-like family, residues 1–638), indicating a conserved, non-enzymatic scaffold typical of the C5orf34-like lineage. This family signature is modularized into four ordered regions: an N-terminal IPR027830 (C5orf34-like, N-terminal domain, residues 7–76), a central IPR053899 (C5orf34-like, second domain, residues 121–258), a downstream IPR053900 (C5orf34-like domain, residues 332–417), and a C-terminal IPR027865 (C5orf34-like, C-terminal domain, residues 448–537). The sequential arrangement of multiple C5orf34-like domains without catalytic motifs argues for a multivalent binding platform rather than an enzyme. Such repeat-like scaffolds commonly mediate avid, selective protein-protein interactions and assembly of regulatory complexes, which causally supports GO:0005515 protein binding as the molecular function.

2. 02

   From this binding-centric architecture, I infer regulatory roles that require spatially organized assemblies.

   The presence of several discrete C5orf34-like modules suggests cooperative assembly of transcriptional regulators and cytoskeletal organizers. This scaffolding capacity provides a mechanistic route to transcriptional repression: by recruiting corepressors and chromatin-modifying factors, the protein can attenuate RNA polymerase II-driven gene expression. This causal chain—multivalent binding leading to assembly of repressor complexes—aligns with GO:0000122 negative regulation of transcription by RNA polymerase II.

3. 03

   Cellular context further constrains function.

   The protein is soluble and detected in the cytoplasm, consistent with GO:0005829 cytosol. Its enrichment at the microtubule-organizing center and centriole-bearing structures indicates a centrosomal role, matching GO:0005813 centrosome. A cytosolic scaffold that concentrates at the centrosome can coordinate two axes: (1) cytoskeletal organization and (2) transcriptional repression via shuttling or indirect assembly pathways. Centrosomal residency provides a physical hub that can influence nuclear signaling indirectly through microtubule-dependent trafficking and cell-cycle–coupled pathways that feed into transcriptional control.

4. 04

   Integrating these lines of evidence yields a mechanistic hypothesis.

   The N-terminal and second C5orf34-like domains (IPR027830 and IPR053899) likely nucleate complexes at the centrosome, while the internal and C-terminal C5orf34-like domains (IPR053900 and IPR027865) expand binding valency to recruit transcriptional repressors and RNA polymerase II modulators. This architecture causes assembly of repressor modules that dampen Pol II transcription, explaining the negative regulatory process. Localization to the centrosome suggests that assembly and signaling are temporally coupled to the cell cycle and microtubule dynamics, with the cytosolic pool supplying diffusible components that can be redirected toward transcriptional control pathways.

5. 05

   I therefore expect the protein to function as a cytosolic, centrosome-enriched scaffold that binds multiple partners (GO:0005515), represses Pol II transcription (GO:0000122) through repressor complex assembly, and resides in the cytosol and at the centrosome (GO:0005829; GO:0005813).

   Likely interaction partners include centrosomal and pericentriolar matrix proteins that anchor the scaffold and transcriptional corepressors that execute repression.